HEALTH

Prestige Brands expands partnership between Goody’s and NASCAR driver Dale Earnhardt Jr.

BY Michael Johnsen

 
 
MARTINSVILLE, Va. — Prestige Brands on Monday reiterated that it is expanding its partnership between Goody's and NASCAR driver Dale Earnhardt Jr. The announcement was first made at the Goody's Headache Relief Shot 500 at Martinsville Speedway on Sunday. Earnhardt went on to win the race.
 
The expanded partnership marks the first time Earnhardt — who has been a spokesperson for Goody’s for the past two years — will drive a Goody’s-sponsored car. Beginning in 2015, and extending through 2017, Earnhardt will drive the No. 88 Goody’s car in one race each year in the NASCAR XFINITY Series.
 
“It has been a pleasure having Dale Jr. as a partner on the Goody’s team,” said Joseph Juliano, brand director for Goody’s. “His success on the track and his commitment to his fans is an inspiration to all of us. We're thrilled he won our sponsored race at Martinsville — it is the perfect start to our expanded partnership.”
 
During pre-race ceremonies, Goody's and Earnhardt also premiered a new video and launched the #Fastest88 Trivia Contest. Beginning Oct. 26, racing fans will have 88 days to enter the contest for a chance to win one of two grand prizes or one of 11 additional prizes.
 
“Working with the Goody’s team has been a great experience for me, and I am excited to be expanding our partnership,” Earnhardt said. “Goody’s is a special brand with many fans that are devoted to its fast pain relief. I am looking forward to meeting some of those fans through the #Fastest88 contest.”
 
The #Fastest88 contest will extend for 88 days, and fans will be quizzed on Earnhardt-related trivia questions. Every eight days from the start of the contest, questions will refresh, with 11 winners being selected by correctly answering the five questions with speed and accuracy. Two grand-prize trips to attend NASCAR races in Martinsville, Va., and Fort Worth, Texas, will be awarded to entrants selected in a random drawing from entries with the highest average score. Contestants can visit Fastest88.com for rules and information.
 
Goody’s Powder, part of the Prestige Brands portfolio, became the first non-automotive sponsor in NASCAR in 1977 when it signed the legendary Richard Petty as a spokesperson. Petty’s partnership with Goody’s thus started one of the longest-running relationships in sports promotion. Earnhardt is a third-generation NASCAR driver and two-time Daytona 500 winner. He has won the National Motorsports Press Association Most Popular Driver Award for 12 years in a row.
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

ROUNDTABLE: Improving patient outcomes, controlling costs with OTCs

BY DSN STAFF

More Americans are more often seeking their ounce of prevention. According to Bain & Co.’s recent Healthy Living Survey, 75% of consumers are in pursuit of a healthier lifestyle. Take that predominant mindset, coupled with the outcomes-driven preventive focus associated with the Affordable Care Act, and you have a formula for OTC success at retail pharmacy.

To get a better sense of how OTC brands are helping to improve patient outcomes and drive down healthcare costs, DSN invited some leading OTC executives to share their opinions on the value of OTCs.


How do you create value in your OTC portfolio considering retailers and health systems are looking for ways to improve patient outcomes and control healthcare costs?

 

T.J. Higgins, president Pfizer Consumer Healthcare North American

Over-the-counter medicines play a vital role in consumer health and wellness, enabling consumers to routinely and effectively manage conditions like muscle pain, allergies, headaches, cold and cough, heartburn and gastrointestinal disorders. Broad availability of OTC medicines empowers consumers to quickly and affordably access treatments when and where they need them, enabling them to live healthier, more productive lives. Pfizer’s effort to move products from prescription to OTC status is a core business imperative and includes a robust R&D program to deliver value and increase consumer access to safe and effective therapies that significantly improve lives.

Pfizer Consumer Healthcare is among the largest over-the-counter healthcare products companies in the world, with a global footprint of operations in more than 90 countries. We maintain leadership positions in many markets and sell two of the top 10 global brands — Advil and Centrum.  PCH develops, manufactures and markets leading nonprescription medicines, vitamins and nutritional products. We strive to bring new and better solutions to market that help consumers around the world support their health and enhance personal well-being. Pfizer’s efforts to expand OTC options represent another chapter in the company’s innovation to significantly improve the lives of patients and bring added value to consumers, healthcare professionals and the public health system overall.

PCH drives growth through major global brands, including Centrum (the world’s No. 1 multivitamin), Caltrate (the world’s No. 1 calcium supplement) and Advil (the world’s No. 1 ibuprofen analgesic brand). The division’s major categories consist of pain management, dietary supplements, respiratory and personal care.

 

Brian McNamara, division head of Novartis OTC

At Novartis Consumer Health, we believe in the power of our OTC brands to help consumers around the world take care of themselves and their families to live healthy lives. Creating accessible and affordable medicines that provide the best patient outcomes is a conscious investment and continuous journey that we endeavor with retail partners and health authorities globally.
 
We start by listening to consumers, like giving headache and migraine sufferers a simple way to share information via the US Excedrin Facebook page. It also means acting on what we hear, like innovating a longer-lasting formulation of our pain-relieving Voltaren gel so that people can get through the day without having to worry about their pain returning.
 
Our products are science-based and benefit-driven. And as part of greater Novartis, we have access to experts and opportunities that can drive our innovation — collaborating with our colleagues at the Novartis Institutes for BioMedical Research, for example, or working with our pharmaceuticals division to determine potential Rx-to-OTC switches within the Novartis portfolio.
 
We also know that retailers, particularly in the United States, want partners who can provide the latest shopper marketing techniques and insights. We invest in these capabilities by regularly conducting shopper research studies and sharing our information with retailers so together we can provide the best OTC solutions that address consumers’ needs.
 
When it comes to curtailing healthcare costs, we know the impact of OTCs and the valuable role self-care plays within healthcare systems. In the United States alone, OTC medicines contribute $102 billion worth of savings in the healthcare system every year.* With trusted and efficacious brands like Excedrin  and Triaminic, we know we’re doing our part to improve health and create value.

*Source:  “The Value of OTC Medicine to the United States,” Booz & Co., Jan. 2012

 

Tim Toll
, executive VP sales
 at Pharmavite

Pharmavite believes that consumers need to be encouraged to lead a healthy lifestyle, which includes balanced diet, exercise and supplements. However, nutrient shortfalls are a reality for most Americans. Dietary supplements are a tool, along with food, that can help consumers optimize nutrient intake when their diets fall short of their nutrient needs. 



According to the latest NHANES data (2010), most Americans fall short of essential nutrients, such as vitamins C and D, calcium, magnesium and omega-3 fatty acids. Supplements may be necessary to optimize intake of certain nutrients.

Pharmavite is working to actively educate pharmacists and other allied healthcare professionals on ways to help guide their patients when choosing supplements. It is extremely important that healthcare professionals assess nutrient intake from food, fortified food and supplements in order to decide how to help consumers optimize nutrient value. 



Nature Made’s portfolio of high-quality products offers solutions to consumers to meet almost every nutrient need they may have.



 

Gary Downing, CEO at Insight Pharmaceuticals

At Insight, the rapid pace of healthcare change has significant impact on our brand discussions and new product strategies as we seek better ways to serve the healthcare needs of consumers. Insight has a diverse OTC portfolio and as the No. 1 nonprescription women’s healthcare company, we understand over-the-counter offerings have an opportunity to play an even greater role in patient’s health. This is particularly true when there are OTC treatment options available that are as effective as prescription options. 

For example, Monistat offers women a self-treatment option for vaginal yeast infections with an OTC medicine that starts providing relief significantly faster than the leading prescription treatment — and is just as effective. As wait times for doctors’ visits continue to grow, highly effective nonprescription treatment options provide a significant value to suffering patients. Women also want to be better informed and take greater control of their health. Therefore, companies like Insight have an opportunity to better educate the public and provide a greater range of preventive and self-use diagnostic tools.   On Monistat, we’ve recently launched a Vaginal Health Test to help symptomatic women determine if they have an elevated vaginal pH, which is a sign of a vaginal infection caused by something other than yeast. This product helps us to educate women that there are other types of infections and helps women to better discern when they may need a physician’s care.    

With Uristat, we relaunched the brand with the first combination pack of its kind to include a test strip that confirms the presence of a urinary tract infection and pain tablets for immediate relief should she have to wait on a prescription.  As health care continues to evolve, OTC companies have a significant opportunity to play a greater leadership role in educating the patient, providing effective treatment options and promoting preventive care.

  

Nick Rini, VP global sales at i-Health

We realize the increased consumer interest in preventive care solutions due to the rise of modern health issues, increasing costs and needs.  We are committed to improving the lives of our consumers through innovative and effective natural and over-the-counter consumer health products in digestion, women’s health, brain health and immunity. We create products based on the consumer need that are supported by science and are offered at a value that encourages consumers to continue with the regimen enhancing their lives and their overall health.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

IRI shares best practices for Rx-to-OTC switch

BY Ryan Chavis

CHICAGO and ORLANDO, Fla. — Prescription and over-the-counter products are often the first remedy consumers turn to when seeking relief from such conditions as allergies and heartburn, according to IRI. In its latest report, "Best Practices for Rx-to-OTC Product Launches," the company offers some tactics to help drive success for companies looking to execute the category switch.

“When studying Rx-to-OTC switches, we found that order of entry is one factor, but it is not necessarily the driving factor for success,” said Robert Sanders, EVP and healthcare practice leader at IRI. “More specifically, the concept of an unmet consumer need continues to trump many of the other variables.”

The report takes a closer look at previous Rx-to-OTC product launches and gathers best practices to adhere to, as well as some missteps to avoid.

“We know that a new wave of Rx-to-OTC products will drive OTC growth in the long term,” Sanders said. “Lessons learned from previous case studies will help maximize success for future brands as they move into this space.”

To download the free report, click here.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?